 |
|---|
| As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
|---|
|
|---|
7:00am† Eledon Pharmaceuticals, Inc. 10-Q 3/31/24 60:5.9M Donnelley … Solutions/FA
5/13/24 Biotechnology Value Fund LP 4 %Own.,Oth.² 1:53K Eledon Pharmaceuticals, Inc. Olshan Frome Wolosky LLP
Biotechnology Value Fund II LP
Biotechnology Value Trading Fund OS LP
BVF GP Holdings LLC
BVF I GP LLC
BVF II GP LLC
BVF Inc./IL
BVF Partners LP/IL
BVF Partners OS Ltd.
Lampert Mark N
5/13/24 Eledon Pharmaceuticals, Inc. 8-K:2,9 5/9/24 9:314K Donnelley … Solutions/FA
5/7/24 Eledon Pharmaceuticals, Inc. 8-K:1,3,7,9 5/6/24 13:1.2M Donnelley … Solutions/FA
4/26/24 Eledon Pharmaceuticals, Inc. 10-K/A 12/31/23 10:2.6M Donnelley … Solutions/FA
3/28/24 Eledon Pharmaceuticals, Inc. 10-K 12/31/23 74:12M Donnelley … Solutions/FA
3/28/24 Eledon Pharmaceuticals, Inc. 8-K:2,9 3/28/24 9:315K Donnelley … Solutions/FA
2/14/24 Armistice Capital, LLC SC 13G 1:88K Eledon Pharmaceuticals, Inc. Adviser Compliance … LLC
2/14/24 Cormorant Asset Management, LP SC 13G/A 1:75K Eledon Pharmaceuticals, Inc. Bingham McCutchen LLP/FA
Bihua Chen³
Cormorant Global Healthcare GP, LLC³
Cormorant Global Healthcare Master Fund, LP³
2/14/24 Biotechnology Value Fund LP SC 13G/A 1:274K Eledon Pharmaceuticals, Inc. Olshan Frome Wolosky LLP
11/9/23 Eledon Pharmaceuticals, Inc. 10-Q 9/30/23 63:6.7M Donnelley … Solutions/FA
11/9/23 Eledon Pharmaceuticals, Inc. 8-K:2,9 11/9/23 11:372K Donnelley … Solutions/FA
11/2/23 Eledon Pharmaceuticals, Inc. 8-K:7,9 11/2/23 12:8.2M Donnelley … Solutions/FA
10/3/23 Robinson James A. Jr. 4 Director² 1:5K Eledon Pharmaceuticals, Inc. DONNELLEY FIN… File16/FA
10/3/23 Kirk Allan 4 Director² 1:5K Eledon Pharmaceuticals, Inc. DONNELLEY FIN… File16/FA
10/2/23 Robinson James A. Jr. 3 Director² 2:7K Eledon Pharmaceuticals, Inc. DONNELLEY FIN… File16/FA
10/2/23 Kirk Allan 3 Director² 2:7K Eledon Pharmaceuticals, Inc. DONNELLEY FIN… File16/FA
10/2/23 Eledon Pharmaceuticals, Inc. 8-K:5 9/29/23 10:154K Donnelley … Solutions/FA
9/21/23‡ Eledon Pharmaceuticals, Inc. 8-K:5,9 9/20/23 11:328K Donnelley … Solutions/FA
9/13/23 Eledon Pharmaceuticals, Inc. 8-K:5 9/11/23 10:154K Donnelley … Solutions/FA
| ____________ | | † | The Filing’s time of SEC acceptance (U.S. Eastern Time). The SEC’s Filings System is “open” Monday through Friday from 6am to 10pm ET.
Because the SEC “closes” at 5:30pm ET, most subsequently-accepted Filings won’t be released to the public until sometime after 6am ET the next day. | | ‡ | A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET. The legal “Filed As Of” date may be the next, or another, day. | | ¹ | Filing/Form Types: | | 3 | Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 { The Filer is an Insider² of the Issuer }. | | 4 | Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }. | | 8-K | Current Report — Form 8-K { Item 1: Business & Operations; 2: Financial Info; 3: Securities & Trading; 4: Accountants & Accounting; 5: Governance & Management; 6: Asset-Backed Securities; 7: Disclosures; 8: Events; 9: Financials }. | | 10-K | Annual Report — Form 10-K. | | 10-Q | Quarterly Report — Form 10-Q. | | SC 13G | Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G. | | /A | Amendment to, or Amended version of, a previous Filing of this Type. | | ² | Insider: The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer. | | ³ | Group Member: A Registrant or non-Registrant party to this Filing made by a Group. |
|
